Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000932312 | SCV001077994 | likely benign | Familial hypercholesterolemia | 2024-01-14 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000932312 | SCV001345165 | likely benign | Familial hypercholesterolemia | 2019-06-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003169358 | SCV003866492 | likely benign | Cardiovascular phenotype | 2023-03-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004003245 | SCV004820109 | likely benign | Hypercholesterolemia, familial, 1 | 2023-07-19 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000932312 | SCV002086356 | likely benign | Familial hypercholesterolemia | 2021-02-20 | no assertion criteria provided | clinical testing |